CHEMICAL & BIOMOLECULAR ENGINEERING

UD Home A-Z Index MyUD Business Maps People Directory

Faculty Position - Department of Chemical and Biomolecular Engineering

The Department of Chemical and Biomolecular Engineering seeks faculty candidates to develop and lead a vigorous and nationally recognized research program; teach and advise students at both the undergraduate and graduate levels; and participate in and contribute to the departmental and larger professional community.

Click here for more information or to apply for this position.


Save the Date:

Feb. 18-24: Engineers Week 2018 Commencement Information


BREAKING THE RULES OF BRAIN CANCER: UD's Dhurjati, Galileo develop accurate model of how aggressive cancer cells move and spread

Feb. 13, 2018--The collaboration of Prof. Prasad Dhurjati, a chemical engineer who has done extensive computer modeling of biological and engineering systems, and Prof. Deni Galileo, a neurobiologist whose expertise is in cell motion and behavior in the brain, has produced a new and freely available computer program that predicts cancer cell motion and spread with high accuracy. An article on their model was recently published in BMC Systems Biology.


PAPOUTSAKIS ELECTED TO NATIONAL ACADEMY OF ENGINEERING: Chemical engineer joins top engineering ranks

Feb. 8, 2018--Eleftherios (Terry) Papoutsakis, Unidel Eugene du Pont Chair of Chemical and Biomolecular Engineering at the University of Delaware, has been elected to the National Academy of Engineering (NAE). He was selected “for contributions to metabolic engineering, especially the industrial biotechnology of Clostridia, and to biomanufacturing of therapeutic proteins.” Clostridia are industrial organisms that Papoutsakis’ lab has worked on for many years to develop their industrial applications.


Delaware Membrane Protein Symposium: Monday, April 30, 2018

Membrane proteins are critical for cell-cell recognition, inter- and intracellular signaling, transmembrane transport and cell homeostasis, and are of great interest in understanding human disease and as drug targets. Join us at our 2018 Symposium for an opportunity to hear and speak to researchers in this field. Click here to for more information and register for this event.


FEB. 18-24: ENGINEERS WEEK: Events celebrate wonders of engineering

Feb. 5, 2018--The University of Delaware will join organizations across the country in celebrating National Engineers Week, Feb. 18-24. Engineers Week is aimed at expanding awareness about how engineering improves the world, from the clean drinking water we consume to the cars we drive. It’s also an opportunity for outreach to the next generation of engineers. This year’s theme is "Engineers: Inspiring Wonder."


STARVING LIVER CANCER: Researchers discover two-step process to thwart cancer cells

Feb. 1, 2018--Scientists at the University of Delaware and the University of Illinois at Chicago have found a new way to kill liver cancer cells and inhibit tumor growth. First, they silence a key cellular enzyme, and then they add a powerful drug. They describe their methods in a new paper published in Nature Communications.


DELAWARE BIOSCIENCE CAT GRANTS: 12 collaborative grants funded in 2017

Jan. 23, 2018--The Delaware Bioscience Center for Advanced Technology (Bioscience CAT) awarded twelve Applied Research Collaborations or Entrepreneurial Proof of Concept grants in 2017. Bioscience CAT is funded by the state of Delaware and is administered by the Delaware Biotechnology Institute (DBI). DBI promotes partnerships across Delaware's academic research organizations, including the University of Delaware, Delaware State University, Christiana Care Health System, Nemours/AI DuPont Hospital for Children, Wesley College, and Delaware Technical and Community College.


NIIMBL PROJECT FUNDING AVAILABLE: National Institute for Innovation in Manufacturing Biopharmaceuticals makes first full project call

Dec. 19, 2017--The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), the Manufacturing USA institute headquartered at UD, is pleased to announce it has released its first full project call. Project Call 1.0 requests proposals that address technology and/or workforce development issues in biopharmaceutical manufacturing. NIIMBL fosters collaboration between industry, academia and federal agencies in developing innovative technologies to advance U.S. biopharmaceutical manufacturing. In addition to new technologies, NIIMBL also addresses workforce development issues and supports the development of standards that enable more efficient manufacturing capabilities.


»More CBE News



Bookmark and Share